Top Scientists Join Arthritis National Research Foundation’s Scientific Advisory Board
Long Beach, Calif. (PRWEB) August 11, 2016 -- Arthritis National Research Foundation (ANRF), a nonprofit dedicated solely to arthritis research, today announced new members to its world-renowned Scientific Advisory Board. Betty Diamond, M.D. and Paul J. Utz, M.D., Ph.D. will bring their expertise and experience to help fund research seeking a cure for arthritis. ANRF funds grants to innovative researchers studying new treatments and cures for arthritis and related autoimmune diseases. The combined experience and expertise of the members of the Scientific Advisory Board ensures all scientists receiving a grant will make outstanding contributions to the field of arthritis research.
Tweet This: Top Scientists Join @ArthritisNRF’s World-Renowned Scientific Advisory Board #CureArthritis
The ANRF Scientific Advisory Board is made up of volunteer physicians and scientists who review every grant application to determine which applicants have the most potential to significantly move arthritis research forward and closer to a cure. In addition, the Scientific Advisory Board advises ANRF on current research trends, treatments, and potential funding opportunities that help keep the Foundation dynamic and forward-thinking. Several previous grant recipients now serve as members of the Scientific Advisory Board, including Dr. P.J. Utz, who was funded in 1998–1999.
Dr. Paul Utz is a board-certified rheumatologist (specialist in arthritis) and Professor of Medicine at Stanford University. Dr. Utz’s lab is currently focusing on implementing new technologies targeted at multiple immune diseases. He also heads one of the Rheumatoid Arthritis/Lupus Network Leadership Centers for the Accelerating Medicines Partnership, a collaboration of academic research, pharmaceutical companies and the National Institutes of Health to accelerate research for these diseases. After earning his M.D. at Stanford in 1991, he served as a faculty member at the Harvard Medical School in 1996, joining the faculty of Stanford in 1999.
Dr. Betty Diamond is the Head of the Center of Autoimmune and Musculoskeletal Diseases at the Feinstein Institute for Medical Research and Professor of Molecular Medicine at Hofstra-Northwell School of Medicine. Her lab is currently studying B cells and their roles in systemic lupus erythematosus (lupus) and the effect of antibodies on cognitive functioning within people with autoimmune diseases. After receiving her M.D. from Harvard Medical School, Dr. Diamond served as head of rheumatology at both Columbia University and the Albert Einstein School of Medicine.
About Arthritis National Research Foundation
Since 1970, the Arthritis National Research Foundation, based in Long Beach, Calif., has supported outstanding young scientists who have become innovators and leaders in the field of rheumatic disease research, autoimmunity and inflammation. From the discovery of tumor necrosis factor (the molecule that initiates inflammation in arthritis) to genes involved in lupus, their research accomplishments have made an impact in the field of arthritis research. ANRF’s approach is to fund the next generation of researchers to encourage their continued commitment to research in arthritis and related diseases. These scientists, supported by ANRF funds, will lead the scientific charge for a deeper understanding of the genetics and molecular mechanisms of the immune system and autoimmune diseases. This new understanding, we believe, will provide the scientific facts and key information to develop new therapies that can alleviate the suffering of patients with arthritis and related diseases.
Ninety-one cents of every dollar donated is placed into research programs. ANRF has received the highest, four-star rating from online evaluator, Charity Navigator, for eight consecutive years, placing them in the top 2% of all charities.
For more information, please visit CureArthritis.org
###
Derek Belisle, Arthritis National Research Foundation, http://www.CureArthritis.org, +1 (800) 588-2873, [email protected]
Share this article